Pages that link to "Q36313967"

The following pages link to Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design (Q36313967):

Displaying 43 items.

• The cellular and molecular basis for malaria parasite invasion of the human red blood cell (Q21032502) (← links)
• Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria (Q26772878) (← links)
• Recent insights into apicomplexan parasite egress provide new views to a kill (Q27023611) (← links)
• Inhibitory potential of prodomain of Plasmodium falciparum protease serine repeat antigen 5 for asexual blood stages of parasite (Q28479056) (← links)
• Protease inhibitors from marine actinobacteria as a potential source for antimalarial compound (Q28540732) (← links)
• Plasmodium falciparum SERA5 plays a non-enzymatic role in the malarial asexual blood-stage lifecycle (Q30046956) (← links)
• In silico approach to ascertain the calcium dependent role of Plasmodium falciparum SERA5. (Q30383100) (← links)
• Genetic and structural characterization of PvSERA4: potential implication as therapeutic target for Plasmodium vivax malaria (Q30429329) (← links)
• Inhibition of malaria parasite development by a cyclic peptide that targets the vital parasite protein SERA5. (Q33347981) (← links)
• Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity (Q33381649) (← links)
• Clues to evolution of the SERA multigene family in 18 Plasmodium species (Q33851402) (← links)
• The Plasmodium falciparum pseudoprotease SERA5 regulates the kinetics and efficiency of malaria parasite egress from host erythrocytes (Q33880801) (← links)
• The Plasmodium serine-type SERA proteases display distinct expression patterns and non-essential in vivo roles during life cycle progression of the malaria parasite (Q33885507) (← links)
• Protease-associated cellular networks in malaria parasite Plasmodium falciparum (Q34173524) (← links)
• Predicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria (Q34303373) (← links)
• The role of serine-type serine repeat antigen in Plasmodium yoelii blood stage development (Q34698064) (← links)
• Global identification of multiple substrates for Plasmodium falciparum SUB1, an essential malarial processing protease (Q34739743) (← links)
• Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target. (Q36045121) (← links)
• Development and Application of a Simple Plaque Assay for the Human Malaria Parasite Plasmodium falciparum (Q36058850) (← links)
• Proteolytic activation of the essential parasitophorous vacuole cysteine protease SERA6 accompanies malaria parasite egress from its host erythrocyte (Q36368252) (← links)
• Recent advances in recombinant protein-based malaria vaccines (Q36394182) (← links)
• Molecular and biochemical characterization of a cathepsin B-like protease family unique to Trypanosoma congolense (Q36538973) (← links)
• Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon (Q36835626) (← links)
• Robust inducible Cre recombinase activity in the human malaria parasite Plasmodium falciparum enables efficient gene deletion within a single asexual erythrocytic growth cycle (Q37001788) (← links)
• Malarial proteases and host cell egress: an 'emerging' cascade (Q37029523) (← links)
• Expression and processing of Plasmodium berghei SERA3 during liver stages. (Q37035500) (← links)
• Improved prediction of malaria degradomes by supervised learning with SVM and profile kernel (Q37290269) (← links)
• A key role for Plasmodium subtilisin-like SUB1 protease in egress of malaria parasites from host hepatocytes. (Q37311442) (← links)
• LISP1 is important for the egress of Plasmodium berghei parasites from liver cells (Q37414542) (← links)
• TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccine (Q37771945) (← links)
• Threonine peptidases as drug targets against malaria (Q37833642) (← links)
• Falcipains and Other Cysteine Proteases of Malaria Parasites (Q37887586) (← links)
• Proteases as regulators of pathogenesis: examples from the Apicomplexa. (Q37891227) (← links)
• Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate (Q37896256) (← links)
• Plasmodium food vacuole plasmepsins are activated by falcipains (Q39647939) (← links)
• CA/C1 peptidases of the malaria parasites Plasmodium falciparum and P. berghei and their mammalian hosts--a bioinformatical analysis (Q47910895) (← links)
• Calcium-dependent phosphorylation of Plasmodium falciparum serine repeat antigen-5 triggers merozoite egress. (Q54113173) (← links)
• A tutorial of diverse genome analysis tools found in the CoGe web-platform using Plasmodium spp. as a model. (Q54941026) (← links)
• Identification and validation of a novel panel of Plasmodium knowlesi biomarkers of serological exposure. (Q55405299) (← links)
• Isoforms of Cathepsin B1 in Neurotropic Schistosomula of Trichobilharzia regenti Differ in Substrate Preferences and a Highly Expressed Catalytically Inactive Paralog Binds Cystatin (Q90347617) (← links)
• Characteristic features of the SERA multigene family in the malaria parasite (Q91607110) (← links)
• Validation of Plasmodium falciparum dUTPase as the target of 5'-tritylated deoxyuridine analogues with anti-malarial activity (Q91651580) (← links)
• First-in-human randomised trial and follow-up study of Plasmodium falciparum blood-stage malaria vaccine BK-SE36 with CpG-ODN(K3) (Q100433599) (← links)